Vitalograph and Thorasys Unite for Enhanced Respiratory Testing with New Oscillometer Vitalograph and Thorasys have joined forces to unveil the Tremoflo® C2 oscillometer, aiming to enhance respiratory diagnostics for patients throughout the U.S.

Vitalograph and Thorasys Unite for Enhanced Respiratory Testing with New Oscillometer #United_States #San_Francisco #Respiratory_Diagnostics #Tremoflo_C2 #Vitalograph

Global Respiratory Diagnostics Market Projected to Reach $9.02 Billion by 2030 The respiratory diagnostics market is expected to grow from $5.85 billion in 2023 to $9.02 billion by 2030, driven by rising health concerns and technology advancements.

Global Respiratory Diagnostics Market Projected to Reach $9.02 Billion by 2030 #USA #Delray_Beach #Respiratory_Diagnostics #Chronic_Obstructive_Pulmonary_Disease #Spirometry